The study also explored the influence of miR-6809-3p on the TGF-β1/SMAD2/3 signaling pathways in GC cells, revealing a suppression of TGF-β1 and p-SMAD2/3 protein expression (Fig. 4L–M). The gene discussed is SMAD2; the disease is gastric cancer.